Bacteria in the gut have been implicated in autoimmune diseases, like lupus, that don't primarily affect the gastrointestinal ...
An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...
Dazukibart is under clinical development by Pfizer and currently in Phase II for Systemic Lupus Erythematosus. According to GlobalData, Phase II drugs for Systemic Lupus Erythematosus have a 39% phase ...
WEDNESDAY, Jan. 15, 2024 (HealthDay News) -- People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the arteries. Lupus “was associated with an ...
Lupus panniculitis is a rare type of lupus. It causes painful lumps under the skin that may lead to scarring. Treatments can help reduce the risk of complications. Lupus is a chronic autoimmune ...
Chilblain lupus erythematosus (CHLE) is a rare type of cutaneous lupus erythematosus (CLE). Symptoms, such as lesions and swelling, can develop after exposure to cold temperatures. CHLE may have a ...
Send your kids to these sites to help them learn, study, indulge their curiosity, and get a fresh perspective on academic subjects. I've been contributing to PCMag since 2011 in a variety of ways ...
Although the age of onset of lupus is typically between 15 and 44 years old, up to 25% of people diagnosed with systemic lupus erythematosus (SLE) have late-onset lupus. Lupus is most commonly ...
Interim data from the Phase 1b studies of imvotamab for people with rheumatoid arthritis and systemic lupus erythematosus (SLE) show that the depth and consistency of B cell depletion did not meet the ...
With a novel approach, they had put a young woman’s lupus — a case so severe that her organs were failing — into remission. Like other autoimmune diseases, those in which the immune system ...
In the Phase 2b CARE study, the investigational drug, cenerimod, demonstrated safe and effective results for treatment of adults with moderate-to-severe systemic lupus erythematosus (SLE). The drug’s ...
Objective Traditional initial treatment regimens for lupus nephritis (LN) used oral glucocorticoids (GC) in starting doses up to 1.0 mg/kg/day prednisone equivalent with or without a preceding ...